Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study

Lung Cancer

Volumn 46, Issue 2, 2004, Pages 233-245

  De Rijke, J M ^a   Schouten, L J ^a,b   Velde, G P M Ten ^c   Wanders, S L ^d   Bollen, E C M ^e   Lalisang, R I ^c   Dijck, J A A M Van ^f   Kramer, G W P ^g   Brandt, P A Van Den ^b  

^a Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRO CLINIC   (Netherlands)

^e Sittard Geleen Heerlen   (Netherlands)

^f Integraal Kankercentrum Oost   (Netherlands)

^g RADIAN Jt Ctr Oncol Arnhem/N   (Netherlands)

Author keywords

Comorbidity; Elderly; Lung cancer; Performance status; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK; STANDARD; TASK PERFORMANCE;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DECISION MAKING; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 5044237928     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.03.011     Document Type: Article

References (33)

1. Visser O, Coebergh JW, Schouten LJ. Incidence of cancer in the Netherlands. V.v.I. Kankercentra, editor. Utrecht; 2001.
2. de Rijke J.M., Schouten L.J., Schouten H.C., Jager J.J., Koppejan A.G., van der Brandt P.A., et al. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol ESMO. 7(7):1996;677-685
3. Janssen Heijnen M.L.G., Schipper R.M., Razenberg P.P.A., Crommelin M.A., Coebegh J.W.W., et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 21(2):1998;105-113
4. Brown J.S., et al. Age and the treatment of lung cancer. Thorax. 51(6):1996;564-568
5. Smith T.J., Penberthy L., Desch C.E., Whittemore M., Newschaffer C., Hillner B.E., et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 13(3):1995;235-252
6. Charlson M., Pompei P., Ales K. A new method of classigying prognostic comorbidity in longitudinal studies: developments and validation. J. Chron. Dis. 40:1987;373-383
7. Karnofsky D, Abelman W, Craver L. The use of nitrogen mustard in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1948;1.
8. Zubrod C., Scheniderman M., Frei E. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylenethiophosphoramide. J. Chron. Dis. 11:1960;7-33
9. Paesmans M., Sculier J.P., Libert P., Bureau G., Dabouis G., Thiriaux J., et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. The European Lung Cancer Working Party. J Clin Oncol Am Soc Clin Oncol. 13(5):1995;1221-1230
10. Sobin LH, Wittekind C. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997.
11. Hermanek P, Sobin LH. TNM Classification of malignant tumours. 4th ed. Berlin: Springer-Verlag; 1987.
12. Hermanek P, Sobin LH. TNM classification of malignant tumours. 4th, 2nd revision ed. Berlin: Springer-Verlag; 1992.
13. Study group lung cancer, guideline for diagnostics and treatment for carcinoma of the lung (in Dutch), Limburg IK, Editor, 1997.
14. Guideline for treatment: non-small cell lung carcinoma. Nijmegen: Comprehensive Cancer Centre East; 1988.
15. O'Rourke M.A., Feussner J.R., Feigl P., Laszlo J., et al. Age trends of lung cancer stage at diagnosis, implications for lung cancer screening in the elderly. JAMA. 258(7):1987;921-926
16. Teeter S.M., Holmes F.F., McFarlane M.J. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer. 60(6):1987;1331-1336
17. Montella M., Gridelli C., Crispo A., Scognamiglio F., Ruffolo P., Gatani J., et al. Has lung cancer in the elderly different characteristics at presentation? Oncol. Rep. 9(5):2002;1093-1096
18. van Dijck J.A., Festen J., de Kleijn E.M., Kramer G.W., Tjan Heijnen V.C., Verbeek A.L., et al. Treatment and survival of patients with non-small cell lung cancer Stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, the Netherlands. Lung Cancer. 34(1):2001;19-27
19. Patterson C.J., Hocking M., Bond M., Teale C., et al. Retrospective study of radiotherapy for lung cancer in patients aged 75 years and over. Age Ageing. 27(4):1998;515-518
20. Lonardi F., Coeli M., Pavanato G., Adami F., Gioga G., Campostrini F., et al. Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival. Lung Cancer. 28(1):2000;43-50
21. Pignon T., Scalliet P., et al. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol. 46(3):1998;239-248
22. Pignon T., Scalliet P. Radiotherapy in the elderly. Eur J Surg Oncol. 24(5):1998;407-411
23. Olmi P., Ausili Cefaro G. Radiotherapy in the elderly: a multicentric prospective study on 2060 patients referred to 37 Italian radiation therapy centers. Rays. 22(1 Suppl):1997;53-56
24. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 36(4):2000;453-471
25. Aapro M., Extermann M., Repetto L. Evaluation of the elderly with cancer. Ann Oncol ESMO. 11(Suppl 3):2000;223-229
26. Firat S., Gore E., Byhardt R.W. Do "elderly fit" patients have less comorbidity? Int J Radiat Oncol Biol Phys. 55(5):2003;1166-1168
27. Rocha Lima C.M., Herndon J.E., Kosty M., Clamon G., Green M.R., et al. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer. 94(1):2002;181-187
28. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ Clin Res 1995;311(7010):899-909.
29. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999;91(1):66-72.
30. Limburg IK, editor. Werkgroep-Bronchuscarcinomen, Guideline for diagnostics and treatment for carcinoma of the lung (in Dutch); 2000.
31. van Meerbeeck J.P. Staging of non-small cell lung cancer: consensus, controversies and challenges. Lung Cancer. 34(Suppl 2):2001;S95-107
32. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer. 32(1):2001;71-79
33. AM T, editor. Treatment for palliation and patient-doctor communication. Houten/diegem: Bohn Stafleu Van Loghum; 1999.